Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

The race between drug introduction and appearance of microbial resistance. Current balance and alternative approaches.

López-Jácome E, Franco-Cendejas R, Quezada H, Morales-Espinosa R, Castillo-Juárez I, González-Pedrajo B, Fernández-Presas AM, Tovar-García A, Angarita-Zapata V, Licona-Limón P, Martínez-Vázquez M, García-Contreras R.

Curr Opin Pharmacol. 2019 Oct;48:48-56. doi: 10.1016/j.coph.2019.04.016. Epub 2019 May 26. Review.

PMID:
31136908
2.

Antimicrobial susceptibility testing before first-line treatment for Helicobacter pylori infection in patients with dual or triple antibiotic resistance.

Cosme A, Montes M, Ibarra B, Tamayo E, Alonso H, Mendarte U, Lizasoan J, Herreros-Villanueva M, Bujanda L.

World J Gastroenterol. 2017 May 14;23(18):3367-3373. doi: 10.3748/wjg.v23.i18.3367.

3.

Edoxaban versus warfarin in patients with atrial fibrillation.

Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, Špinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EM; ENGAGE AF-TIMI 48 Investigators.

N Engl J Med. 2013 Nov 28;369(22):2093-104. doi: 10.1056/NEJMoa1310907. Epub 2013 Nov 19.

Supplemental Content

Loading ...
Support Center